Intranasal Insulin for the Treatment of Mild Cognitive Impairment and Alzheimer Disease Dementia

Start Date :  Jun 22, 2020End Date :  Jun 22, 2023

Duration :  24 Minutes

Organized by :   American Medical Association (AMA)

Specialties :   Neurology

Fees Fee :   Free

Conference Summary

Intranasal Insulin for the Treatment of Mild Cognitive Impairment and Alzheimer Disease Dementia is organized by American Medical Association (AMA).

Recorded Date: Jun 22, 2020
End Date: Jun 22, 2023 (This activity may be taken for up to 3 years after they are published)

Duration: Audio Author Interview 23 min 54 sec

Description:
Interview with Suzanne Craft, PhD, author of Safety, Efficacy, and Feasibility of Intranasal Insulin for the Treatment of Mild Cognitive Impairment and Alzheimer Disease Dementia: A Randomized Clinical Trial

Additional details will be posted as soon as information is available.

Topic
✔Dementia
  Dementia
Contact Us

Toll free Number

1(800) 826-2059

Email

support@eMedEvents.com

Chat Assistant

Live Chat
Recommended